Bio/Pharma News

Pharma News in Global Health and Sustainability

November 06, 2013

PTSM: Pharmaceutical Technology Sourcing and Management

A roundup of developments in global health and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

J&J Fined $2.2 Billion for Off-label Marketing and Kickbacks

November 04, 2013

Allegations include off-label marketing for Risperdal, Invega and Natrecor and kickbacks to doctors and pharmacists.

GSK, Gates Foundation Seek Heat-Stable Adjuvants for Vaccines

October 29, 2013

GSK and the Gates Foundation will invest a combined $1.8 million in early stage research into vaccine thermostability.

FDA Approves Extended-Release, Single-Entity Hydrocodone Product

October 28, 2013

Zhoydro ER is the first drug to have updated labeling now required for all ER/LA opioid analgesics.

Novartis, Amgen, and Bristol-Myers Squibb Report Sales Up in Third Quarter

October 23, 2013

Big pharma companies Novartis, Amgen, and Bristol-Myers Squibb announce positive third-quarter 2013 results.

Amarin Cuts Staff Following FDA Vote

October 23, 2013

Amarin cuts staff in half after an FDA committee rejects its product label expansion.

FDA Awards 15 Grants to Stimulate Drug, Device Development for Rare Diseases

October 22, 2013

FDA has awarded 15 grants totaling more than $14 million to boost the development of products for patients with rare diseases.

Abbott Reports Third-Quarter 2013 Results

October 21, 2013

Abbott?s third-quarter 2013 global sales increased slightly but were affected by a disruption in the International Nutrition business.

Johnson & Johnson Reports Third-Quarter 2013 Results

October 21, 2013

J&J announces 2013 third-quarter sales increased 3% over 2012 third-quarter sales.

AstraZeneca's MedImmune Acquires Spirogen and Strengthens Antibody-Drug Conjugate Capability

October 15, 2013

MedImmune expands its antibody-drug conjugate capability through acquisition and collaboration.